Terms: = Lung cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Diagnosis
1121 results:
1. Utilizing Deep Learning and Computed Tomography to Determine Pulmonary Nodule Activity in Patients With Nontuberculous Mycobacterial-lung Disease.
Lancaster AC; Cardin ME; Nguyen JA; Mehta TI; Oncel D; Bai HX; Cohen KA; Lin CT
J Thorac Imaging; 2024 May; 39(3):194-199. PubMed ID: 38640144
[TBL] [Abstract] [Full Text] [Related]
2. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract] [Full Text] [Related]
3. Enhancing diagnosis of benign lesions and lung cancer through ensemble text and breath analysis: a retrospective cohort study.
Wang H; Wu Y; Sun M; Cui X
Sci Rep; 2024 Apr; 14(1):8731. PubMed ID: 38627587
[TBL] [Abstract] [Full Text] [Related]
4. Multiomics-Based Feature Extraction and Selection for the Prediction of lung cancer Survival.
Jaksik R; Szumała K; Dinh KN; Śmieja J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612473
[TBL] [Abstract] [Full Text] [Related]
5. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract] [Full Text] [Related]
6. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
PeerJ; 2024; 12():e17141. PubMed ID: 38529301
[TBL] [Abstract] [Full Text] [Related]
7. Development of a modified 3D region proposal network for lung nodule detection in computed tomography scans: a secondary analysis of lung nodule datasets.
Lin CY; Guo SM; Lien JJ; Tsai TY; Liu YS; Lai CH; Hsu IL; Chang CC; Tseng YL
Cancer Imaging; 2024 Mar; 24(1):40. PubMed ID: 38509635
[TBL] [Abstract] [Full Text] [Related]
8. [A clinical-radiomics nomogram for differentiating focal organizing pneumonia and lung adenocarcinoma].
Liu Y; Li C; Guo J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):397-404. PubMed ID: 38501426
[TBL] [Abstract] [Full Text] [Related]
9. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-cancer Clinicogenomic Data set.
Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
[TBL] [Abstract] [Full Text] [Related]
10. Dual-layer detector spectral CT-based machine learning models in the differential diagnosis of solitary pulmonary nodules.
Lu H; Liu K; Zhao H; Wang Y; Shi B
Sci Rep; 2024 Feb; 14(1):4565. PubMed ID: 38403645
[TBL] [Abstract] [Full Text] [Related]
11. Computed Tomography Radiomics for Preoperative Prediction of Spread Through Air Spaces in the Early Stage of Surgically Resected lung Adenocarcinomas.
Suh YJ; Han K; Kwon Y; Kim H; Lee S; Hwang SH; Kim MH; Shin HJ; Lee CY; Shim HS
Yonsei Med J; 2024 Mar; 65(3):163-173. PubMed ID: 38373836
[TBL] [Abstract] [Full Text] [Related]
12. Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned.
Borgers JSW; van Schijndel AW; van Thienen JV; Klobuch S; Seijkens TTP; Tobin RP; van Heerebeek L; Driessen-Waaijer A; Rohaan MW; Haanen JBAG
ESMO Open; 2024 Feb; 9(2):102383. PubMed ID: 38364453
[TBL] [Abstract] [Full Text] [Related]
13. HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer.
Saigí M; Mate JL; Carcereny E; Martínez-Cardús A; Esteve A; Andreo F; Centeno C; Cucurull M; Mesia R; Pros E; Sanchez-Cespedes M
Lung Cancer; 2024 Mar; 189():107502. PubMed ID: 38359742
[TBL] [Abstract] [Full Text] [Related]
14. Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.
Wu P; Zhang C; Tang X; Li D; Zhang G; Zi X; Liu J; Yin E; Zhao J; Wang P; Wang L; Li R; Wu Y; Sun N; He J
Mol Cancer; 2024 Feb; 23(1):31. PubMed ID: 38347558
[TBL] [Abstract] [Full Text] [Related]
15. Radiomics signature based on robust features derived from diffusion data for differentiation between benign and malignant solitary pulmonary lesions.
Zhou J; Wen Y; Ding R; Liu J; Fang H; Li X; Zhao K; Wan Q
Cancer Imaging; 2024 Jan; 24(1):14. PubMed ID: 38246984
[TBL] [Abstract] [Full Text] [Related]
16. Few-shot segmentation framework for lung nodules via an optimized active contour model.
Yang L; Shao D; Huang Z; Geng M; Zhang N; Chen L; Wang X; Liang D; Pang ZF; Hu Z
Med Phys; 2024 Apr; 51(4):2788-2805. PubMed ID: 38189528
[TBL] [Abstract] [Full Text] [Related]
17. "All in one" nanoprobe Au-TTF-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
[TBL] [Abstract] [Full Text] [Related]
18. Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma.
Yang S; Li K; Zhang J; Liu J; Liu L; Tan Y; Xu C
Exp Biol Med (Maywood); 2023 Dec; 248(23):2273-2288. PubMed ID: 38166412
[TBL] [Abstract] [Full Text] [Related]
19. Segmentation of lung nodules based on a refined segmentation network.
Chen Y; Hou X; Yang Y; Zhou Y; Xie Y; Nie S
Med Phys; 2024 Apr; 51(4):2759-2771. PubMed ID: 38108587
[TBL] [Abstract] [Full Text] [Related]
20. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis.
Jiang Y; Deng T; Huang Y; Ren B; He L; Pang M; Jiang L
PeerJ; 2023; 11():e16539. PubMed ID: 38107565
[TBL] [Abstract] [Full Text] [Related]
[Next]
